ThrombocytopeniaKeith R. McCrae Taylor & Francis, 6 במרץ 2006 - 336 עמודים The first and only source to offer an all-encompassing approach to the pathogenesis and treatment of thrombocytopenic disorders, this book reviews current information concerning thrombocytopenia due to diminished platelet production and accelerated immunologic and nonimmunologic platelet clearance, as well as a detailed review of medications that cause this disorder. |
תוכן
Biology and Potential Clinical | 17 |
Congenital Inherited Familial | 55 |
Thrombocytopenia Due to Deficient Platelet | 75 |
זכויות יוצרים | |
16 קטעים אחרים שאינם מוצגים
מהדורות אחרות - הצג הכל
מונחים וביטויים נפוצים
abciximab acute ADAMTS13 adults anti-D antigens antiplatelet apheresis aplastic anemia argatroban assay associated Aster RH autoantibodies autoimmune binding bleeding Blood bone marrow c-Mpl cause chemotherapy chronic clearance Clin clinical complex congenital corticosteroids cytopenia deficiency detection diagnosis disease disorders donor dose drug drug-induced thrombocytopenia effects factor Fcy receptors FcyRIIa fetal gene glycoprotein Haematol hematopoietic hemolytic hemorrhage heparin heparin-induced thrombocytopenia hepatitis HIT antibodies human idiopathic thrombocytopenic purpura IIb/IIIa immune thrombocytopenia immune thrombocytopenic purpura increased induced infection inhibitors intravenous IVIG lepirudin leukemia levels mechanisms megakaryocytes mice mutation normal occur patients Pediatr PEG-rHuMGDF plasma exchange platelet activation platelet count platelet destruction platelet function platelet production platelet transfusions platelet-specific pregnancy protein recombinant refractory renal reported response rhTPO risk Rituximab severe thrombocytopenia specific splenectomy stem cell studies therapy Thromb Haemost thrombin thrombocyto thrombopoietin thrombosis thrombotic microangiopathy thrombotic thrombocytopenic purpura topenia transplantation treatment uremic syndrome vitro Warkentin Willebrand